Ameritas Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.71K | Hold |
30
| – | – | ﹤0.01% | 3091 |
|
|
2026
Q1 | $5.07K | Hold |
30
| – | – | ﹤0.01% | 2991 |
|
|
2025
Q4 | $5.06K | Hold |
30
| – | – | ﹤0.01% | 3031 |
|
|
2025
Q3 | $4.33K | Hold |
30
| – | – | ﹤0.01% | 3068 |
|
|
2025
Q2 | $3.79K | Hold |
30
| – | – | ﹤0.01% | 3127 |
|
|
2025
Q1 | $3.84K | Hold |
30
| – | – | ﹤0.01% | 3021 |
|
|
2024
Q4 | $3.97K | Hold |
30
| – | – | ﹤0.01% | 3055 |
|
|
2024
Q3 | $4.37K | Hold |
30
| – | – | ﹤0.01% | 3055 |
|
|
2024
Q2 | $4.12K | Hold |
30
| – | – | ﹤0.01% | 3048 |
|
|
2024
Q1 | $4.12K | Hold |
30
| – | – | ﹤0.01% | 2975 |
|
|
2023
Q4 | $4.08K | Hold |
30
| – | – | ﹤0.01% | 3003 |
|
|
2023
Q3 | $3.67K | Hold |
30
| – | – | ﹤0.01% | 3025 |
|
|
2023
Q2 | $3.81K | Hold |
30
| – | – | ﹤0.01% | 3057 |
|
|
2023
Q1 | $3.88K | Hold |
30
| – | – | ﹤0.01% | 2905 |
|
|
2022
Q4 | $3.94K | Hold |
30
| – | – | ﹤0.01% | 2953 |
|
|
2022
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 2978 |
|
|
2022
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 3004 |
|
|
2022
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 3025 |
|
|
2021
Q4 | $4K | Hold |
30
| – | – | ﹤0.01% | 3056 |
|
|
2021
Q3 | $4K | Hold |
30
| – | – | ﹤0.01% | 3045 |
|
|
2021
Q2 | $4K | Hold |
30
| – | – | ﹤0.01% | 3006 |
|
|
2021
Q1 | $4K | Hold |
30
| – | – | ﹤0.01% | 3027 |
|
|
2020
Q4 | $4K | Hold |
30
| – | – | ﹤0.01% | 2998 |
|
|
2020
Q3 | $4K | Hold |
30
| – | – | ﹤0.01% | 3006 |
|
|
2020
Q2 | $4K | Hold |
30
| – | – | ﹤0.01% | 2989 |
|
|
2020
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 2910 |
|
|
2019
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 2947 |
|
|
2019
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 3018 |
|
|
2019
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 2989 |
|
|
2019
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 2917 |
|
|
2018
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 2949 |
|
|
2018
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 2990 |
|
|
2018
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 2970 |
|
|
2018
Q1 | $3K | Sell |
30
-259
| -90% | -$28.7K | ﹤0.01% | 2905 |
|
|
2017
Q4 | $102K | Buy |
289
+1
| +0.3% | +$107 | ﹤0.01% | 1492 |
|
|
2017
Q3 | $32K | Hold |
288
| – | – | ﹤0.01% | 2152 |
|
|
2017
Q2 | $29K | Hold |
288
| – | – | ﹤0.01% | 2247 |
|
|
2017
Q1 | $28K | Hold |
288
| – | – | ﹤0.01% | 2198 |
|
|
2016
Q4 | $25K | Sell |
288
-159
| -36% | -$14.5K | ﹤0.01% | 1160 |
|
|
2016
Q3 | $43K | Hold |
447
| – | – | ﹤0.01% | 1107 |
|
|
2016
Q2 | $38K | Sell |
447
-36
| -7% | -$3.23K | ﹤0.01% | 1047 |
|
|
2016
Q1 | $41K | Hold |
483
| – | – | ﹤0.01% | 1039 |
|
|
2015
Q4 | $54K | Buy |
483
+297
| +160% | +$32.2K | ﹤0.01% | 1017 |
|
|
2015
Q3 | $18K | Hold |
186
| – | – | ﹤0.01% | 1047 |
|
|
2015
Q2 | $22K | Hold |
186
| – | – | ﹤0.01% | 1090 |
|
|
2015
Q1 | $21K | Hold |
186
| – | – | ﹤0.01% | 1130 |
|
|
2014
Q4 | $18K | Buy |
+186
| New | +$18.1K | ﹤0.01% | 1120 |
|
Other funds holding IBB
CB
Ameritas Investment Partners's IBB Position: Q2 2026 in Review
Ameritas Investment Partners held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 30 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #3091.
Ameritas Investment Partners first reported a position in IBB in Q4 2014 and has held it in 47 quarters since. The position peaked at $102K in Q4 2017. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Ameritas Investment Partners held 30 shares of iShares Biotechnology ETF worth $5.71K as of Q2 2026.
- Ameritas Investment Partners left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #3091 holding.
- Ameritas Investment Partners first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 47 quarters since.
- Ameritas Investment Partners's iShares Biotechnology ETF position peaked at $102K in Q4 2017.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.